Sonora Investment Management’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Sonora Investment Management’s Portfolio QNTM Stock Details QNTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2	Closed	–	–	1799
2020 Q3	$0	Sell	2 -4	-67%	-$831	﹤0.01%	1897
2020 Q2	$1K	Buy	6 +4	+200%	+$937	﹤0.01%	1705
2020 Q1	$1K	Buy	+2	New	+$662	﹤0.01%	1611

Other funds holding QNTM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

RPC

Rossmore Private Capital Glastonbury, Connecticut $1.24B AUM 28.92% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Sonora Investment Management's QNTM Position: Q4 2020 in Review

Sonora Investment Management sold out of Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q4 2020, closing a stake of 2 shares.

Sonora Investment Management first reported a position in QNTM in Q1 2020 and held it in 3 quarters. The position peaked at $1K in Q2 2020. 12 funds tracked by Wall St. Rank hold QNTM as of Q4 2020.

Sonora Investment Management reported no remaining Quantum Biopharma Class B Subordinate Voting Shares position as of Q4 2020 after selling out during the quarter.
Sonora Investment Management sold 2 Quantum Biopharma Class B Subordinate Voting Shares shares in Q4 2020.
Sonora Investment Management first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q1 2020 and held it in 3 quarters.
Sonora Investment Management's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $1K in Q2 2020.
12 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q4 2020.

Based on Sonora Investment Management's 13F filing for Q4 2020, filed 13 Jan 2021.